Dr. Michael Cantor Named Intuition Robotics 1st Chief Medical Officer

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Dr. Michael Cantor will bring his expertise both as a geriatrician and as the former Chief Medical Officer of Bright Health Plan, a Medicare Advantage insurer, to aid the company’s efforts in leveraging ElliQ to bring care to older adults into their homes.

The company recently announced its plan to extend to healthcare.

Before joining Intuition Robotics, Dr. Michael Cantor was the Chief Medical Officer at Bright Health Plan, where he liaised with their network of doctors, clinics and hospitals to provide the best healthcare possible. Before Bright, he was Chief Medical Officer for home healthcare company, CareCentrix, where he worked with payors and providers to create programs that improve quality and lower costs by allowing patients to heal and age at home. Prior to that, he was also the Chief Medical Officer for New England Quality Care Alliance and the New England Deputy Medical Director for UnitedHealthcare.

Dr. Cantor trained in primary care internal medicine and geriatrics at Beth Israel Hospital/Harvard Medical School. He has degrees in law and medicine from the University of Illinois.

The Covid-19 pandemic has accelerated the demand for both in-home and virtual care, especially for older adults. ElliQ’s unique and constant presence in the home, combined with the engagement levels the company has been seeing over the past few years, led the company to seek out a Chief Medical Officer to enhance their offering within the health space.

In his role as Chief Medical Officer, Dr. Michael Cantor will assist in designing ElliQ’s capabilities, working alongside clinical teams to help them deliver better in-home care — liaising between the older adult ElliQ users and the healthcare ecosystem. Dr. Cantor will work closely with physicians to understand the best way to incorporate ElliQ into pathways of care, and how ElliQ can help them effectively improve the quality of their care.

“I’m excited to be joining a company that brings care to the patient, rather than bringing the patient to the care, especially when it comes to older adults,” says Dr. Michael Cantor, MD, Chief Medical Officer of Intuition Robotics. “As a geriatrician, I appreciate how ElliQ allows older adults to age in place by creating stronger connections to the outside world. By adding additional health features to ElliQ, we can holistically support the older adult population by providing social companionship and enhancing relationships with their clinical team.”

“The pandemic showed the importance and challenges of delivering care at home to older adults. It became immediately clear that having ElliQ work together with care teams will dramatically improve the quality of care,” says Dor Skuler, CEO and Co-founder of Intuition Robotics. “We’re thrilled that someone with Dr. Cantor’s level of experience decided to join our company and help us extend ElliQ into healthcare. Dr. Cantor brings vast understanding in geriatric medicine that will no doubt prove crucial to our success.”



Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.